Sfoglia per AUTORE
IOTTI C
Collezione ASL Torino 4

  

Items : 9

Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. in European urology / Eur Urol. 2022 Mar;81(3):274-282. doi: 10.1016/j.eururo.2021.09.016. Epub 2021 Oct 1.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Fantinel E; Timon G; Ciammella P; Buttigliero C; Baier S; Morelli F; Nole F; Caffo O; Procopio G; Lohr F; Bruni A; Vitale MG; Mucciarini C; Mazzarotto R; Zampiva I; Buti S; Salaroli F; Bellia RS; De Giorgi U; Iotti C; Masini C; Carlinfante G; Berselli A; Pinto C;

NTCP models of late severe urinary symptoms after radical IMRT for prostate cancer in Radiotherapy and Oncology

2018
ASL Biella
ASL Torino 4

Palorini F; Cicchetti A; Rancati T; Cozzarini C; Avuzzi B; Botti A; Cante D; Casanova Borca V; Degli Esposti C; Garibaldi E; Girelli G; Iotti C; Maggio A; Munoz F; Palombarini M; Pierelli A; Pignoli E; Vavassori V; Valdagni R; Fiorino C;

Incidence of late severe urinary symptoms after radical imrt for prostate cancer: Effect of bladder doses and hypofractionation in International Journal of Radiation Oncology Biology Physics

2017
ASL Torino 4

Palorini F; Cicchetti A; Rancati T; Cozzarini C; Avuzzi B; Cante D; Esposti CD; Garibaldi E; Iotti C; Munoz F; Vavassori V; Valdagni R; Fiorino C;

Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy. in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology / Radiother Oncol. 2016 Jan;118(1):92-8. doi: 10.1016/j.radonc.2015.11.036. Epub 2016 Jan 6.

2016
ASL Torino 4
ASL Biella

Palorini F; Rancati T; Cozzarini C; Improta I; Carillo V; Avuzzi B; Casanova Borca V; Botti A; Degli Esposti C; Franco P; Garibaldi E; Girelli G; Iotti C; Maggio A; Palombarini M; Pierelli A; Pignoli E; Vavassori V; Valdagni R; Fiorino C;

Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer. in Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) / Phys Med. 2016 Dec;32(12):1681-1689. doi: 10.1016/j.ejmp.2016.08.013. Epub 2016 Aug 25.

2016
ASL Torino 4

Improta I; Palorini F; Cozzarini C; Rancati T; Avuzzi B; Franco P; Degli Esposti C; Del Mastro E; Girelli G; Iotti C; Vavassori V; Valdagni R; Fiorino C;

What happens to testosterone levels after radical radiation therapy for prostate cancer? in International Journal of Radiation Oncology

2016
ASL Torino 4

Avuzzi B; Cozzarini C; Rancati T; Improta I; Palorini F; Badenchini F; Iotti C; Vavassori V; Girelli G; Degli Esposti C; Valdagni R; Fiorino C;

Local dose descriptors correlated with late urinary toxicity at 6 to 24 months after radiation therapy for prostate cancer in International Journal of Radiation Oncology

2016
ASL Torino 4

Rancati T; Improta I; Palorini F; Cozzarini C; Degli Esposti C; Franco P; Garibaldi E; Girelli G; Iotti C; Vavassori V; Valdagni R; Fiorino C;

Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: Results of a cohort study. in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology / Radiother Oncol. 2015 Aug;116(2):185-91. doi: 10.1016/j.radonc.2015.07.048. Epub 2015 Aug 11.

2015
ASL Torino 4

Cozzarini C; Rancati T; Carillo V; Civardi F; Garibaldi E; Franco P; Avuzzi B; Esposti CD; Girelli G; Iotti C; Palorini F; Vavassori V; Valdagni R; Fiorino C;

Multivariable models predicting specific patient-reported acute urinary symptoms after radiation therapy for prostate cancer: Results of a cohort study in International Journal of Radiation Oncology Biology Physics

2015
ASL Torino 4

Rancati T; Cozzarini C; Improta I; Palorini F; Garibaldi E; Franco P; Avuzzi B; Degli Esposti C; Girelli G; Iotti C; Vavassori V; Valdagni R; Fiorino C;